These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37059104)

  • 1. Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.
    Sievers C; Craveiro M; Friedman J; Robbins Y; Yang X; Bai K; Nguyen A; Redman JM; Chari R; Soon-Shiong P; Schlom J; Gulley J; Allen CT
    Cancer Cell; 2023 May; 41(5):887-902.e5. PubMed ID: 37059104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer.
    Redman JM; Friedman J; Robbins Y; Sievers C; Yang X; Lassoued W; Sinkoe A; Papanicolau-Sengos A; Lee CC; Marte JL; Turkbey E; Mydlarz W; Joshi A; London NR; Pierce M; Taylor R; Hong S; Nguyen A; Soon-Shiong P; Schlom J; Gulley JL; Allen CT
    J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35727629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral CD103
    Ren S; Lan T; Wu F; Chen S; Jiang X; Huo C; Li Z; Xie S; Wu D; Wang R; Li Y; Qiu L; Huang G; Li S; Wang X; Cen M; Cai T; Lin Z; Li J; Li B
    Cancer Commun (Lond); 2023 Oct; 43(10):1143-1163. PubMed ID: 37658605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β neutralization attenuates tumor residency of activated T cells to enhance systemic immunity in mice.
    Fay M; Sievers C; Robbins Y; Yang X; Huynh A; Redman JM; Hodge JW; Schlom J; Gulley JL; Allen CT; Craveiro M
    iScience; 2024 Aug; 27(8):110520. PubMed ID: 39139402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin-α
    Malenica I; Adam J; Corgnac S; Mezquita L; Auclin E; Damei I; Grynszpan L; Gros G; de Montpréville V; Planchard D; Théret N; Besse B; Mami-Chouaib F
    Nat Commun; 2021 Sep; 12(1):5209. PubMed ID: 34471106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD103 is a hallmark of tumor-infiltrating regulatory T cells.
    Anz D; Mueller W; Golic M; Kunz WG; Rapp M; Koelzer VH; Ellermeier J; Ellwart JW; Schnurr M; Bourquin C; Endres S
    Int J Cancer; 2011 Nov; 129(10):2417-26. PubMed ID: 21207371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.
    Oliveira G; Egloff AM; Afeyan AB; Wolff JO; Zeng Z; Chernock RD; Zhou L; Messier C; Lizotte P; Pfaff KL; Stromhaug K; Penter L; Haddad RI; Hanna GJ; Schoenfeld JD; Goguen LA; Annino DJ; Jo V; Oppelt P; Pipkorn P; Jackson R; Puram SV; Paniello RC; Rich JT; Webb J; Zevallos JP; Mansour M; Fu J; Dunn GP; Rodig SJ; Ley J; Morris LGT; Dunn L; Paweletz CP; Kallogjeri D; Piccirillo JF; Adkins DR; Wu CJ; Uppaluri R
    Sci Immunol; 2023 Sep; 8(87):eadf4968. PubMed ID: 37683037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive profile of TCF1
    Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
    Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy.
    Luoma AM; Suo S; Wang Y; Gunasti L; Porter CBM; Nabilsi N; Tadros J; Ferretti AP; Liao S; Gurer C; Chen YH; Criscitiello S; Ricker CA; Dionne D; Rozenblatt-Rosen O; Uppaluri R; Haddad RI; Ashenberg O; Regev A; Van Allen EM; MacBeath G; Schoenfeld JD; Wucherpfennig KW
    Cell; 2022 Aug; 185(16):2918-2935.e29. PubMed ID: 35803260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell HLA class I expression and pathologic response following neoadjuvant immunotherapy for newly diagnosed head and neck cancer.
    Robbins Y; Friedman J; Redman J; Sievers C; Lassoued W; Gulley JL; Allen CT
    Oral Oncol; 2023 Mar; 138():106309. PubMed ID: 36682187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4.
    van den Bulk J; Verdegaal EME; Ruano D; Ijsselsteijn ME; Visser M; van der Breggen R; Duhen T; van der Ploeg M; de Vries NL; Oosting J; Peeters KCMJ; Weinberg AD; Farina-Sarasqueta A; van der Burg SH; de Miranda NFCC
    Genome Med; 2019 Dec; 11(1):87. PubMed ID: 31888734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB Agonism Combined With PD-L1 Blockade Increases the Number of Tissue-Resident CD8+ T Cells and Facilitates Tumor Abrogation.
    Qu QX; Zhu XY; Du WW; Wang HB; Shen Y; Zhu YB; Chen C
    Front Immunol; 2020; 11():577. PubMed ID: 32391001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD103
    Wang P; Huang B; Gao Y; Yang J; Liang Z; Zhang N; Fu X; Li L
    Cell Immunol; 2018 Mar; 325():48-55. PubMed ID: 29448979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of PD-L1, transforming growth factor-β expression and tumor-infiltrating CD8
    Duan J; Liu X; Chen H; Sun Y; Liu Y; Bai H; Wang J
    Thorac Cancer; 2018 Nov; 9(11):1341-1353. PubMed ID: 30168897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
    Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
    Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
    Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-Checkpoint Blockade Opposes CD8
    Pfannenstiel LW; Diaz-Montero CM; Tian YF; Scharpf J; Ko JS; Gastman BR
    Cancer Immunol Res; 2019 Mar; 7(3):510-525. PubMed ID: 30728151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.